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Even though proteinuria is related to different causes, when it is persistent and associated with inactive urinary sediment, it is
primarily due to kidney disease. Early detection of proteinuria allows us to identify several pathological conditions. The aim of
the study was screening a canine population not known as being proteinuric, by the urinary dipstick. The study was carried out
in seven Italian veterinary clinics during a period of six weeks. Dogs were enrolled with no restriction of sex or age. Females in
estrus, dogs with signs of genitourinary diseases, or those previously diagnosed with proteinuric nephropathy were excluded. Dogs
were considered “nonproteinuric” (NP) in case of negative dipstick test or “suspected proteinuric” (SP), if positive at the dipstick.
When possible, proteinuria was confirmed by UPC ratio. A total of 1156 dogs were evaluated: 414 were from northern Italy and 742
from southern Italy. Based on dipstick test, 655 (56.6%) dogs were NP, while 501 (43.3%) were SP. Among the NP dogs 225 out of
414 (54.3%) were in northern Italy and 430 of 742 (57.9%) in southern Italy. One hundred eighty-nine of 414 (45.7%) SP dogs were
identified in northern Italy and 312 of 742 (42.1%) in southern Italy. No statistical difference was found between the North and the
South of Italy. UPCwas available in 412 out of 501 SP samples: proteinuria was confirmed in 263 (63.86%) samples. Results from our
study showed a high percentage of suspected proteinuric dogs, apparently not affected by renal diseases, together with the absence
of statistically significant differences based on geographical area.
1. Introduction
Proteinuria is defined as the presence of an excessive amount
of proteins in the urine, or of abnormal proteins that are
not normally present [1–4]. Over the last years, canine pro-
teinuria has assumed a position of prominence and growing
interest enough to be now considered not only a marker of
nephropathy, but also a prognostic factor [2–5]. Proteinuric
dogs, for the same IRIS stage, show a different progression
of the nephropathy depending on the amount of protein lost
in the urine and they have an increased risk of mortality
due to renal causes compared to nonproteinuric dogs [2–
7]. Moreover, the response to the antiproteinuric therapy
influences the progression of the disease: the possibility of
instituting an antiproteinuric therapy, associated with the
early diagnosis of proteinuric nephropathy, has proved to be
effective in reducing the risk of mortality due to renal causes
in several natural models of the disease [3, 4, 7].
Causes of proteinuria of renal origin include either
genetic or infectious diseases, other than all diseases leading
to a chronic stimulation of the immune system and immune-
mediated disorders in general. Many of the underlying
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conditions of the proteinuric nephropathy are not identified
or are identified belatedly and this makes the management
of the renal disease difficult; furthermore, the lack of easily
identifiable clinical signs often makes the diagnosis late.
Being the presence of proteinuria a marker of nephropa-
thy as well as an important prognostic factor in dogs affected
by kidney disease, screening of the population at risk can
assume a role of particular importance as most proteinuric
dogs are not identified at the early stages of the disease
for the lack of clinical signs [3, 4, 7, 8]. In order to carry
it out successfully, the screening of the canine population
not only requires the identification of dogs at risk of the
disease, but also it is necessary that the tests chosen are easy
to use, of low costs, and performed on samples collected
with no invasive procedures. In dogs, the urinary dipstick
for the identification of nonproteinuric patients has been
proposed [2, 9, 10]. Dogs whose urine is negative at the
dipstick can be considered nonproteinuric, while all samples
with positive results should undergo the more sensitive and
specific urinary protein to creatinine ratio (UPC) [10]. Urine
collection by spontaneous micturition (free catch) has also
been validated in dogs [8, 11]. Positive results at dipstick
will require us to rule out any underlying inflammatory
process (through the urinary sediment evaluation), which
will finally allow us to identify false positive results [8, 11].
Prerenal causes of proteinuria determining positive results at
the dipstick are more commonly related to easily identifiable
clinical pictures, such as fever and seizures.
The causal relation between some diseases determining a
chronic stimulation of the immune system and glomerular
disease causing proteinuria in dogs is suspected. Chronic
disease of the skin, as well as periodontal disease, may in
fact represent aetiologically important factors which could
considerably widen the number of dogs at risk of proteinuria
[12, 13].
Since the presence of proteinuria can be associated
with genetic disease or else determined by several diseases
causing glomerular damage on immune-mediated basis and
the proteinuric renal disease is difficult to be identified
(especially in its early stages) if not through laboratory tests,
the identification and the screening of the population at
risk play a key role for the early diagnosis of proteinuric
nephropathy [3, 4, 6, 14]. Breeds at risk of renal disease for
genetic reasons should be screened early (within 6 months of
age), and all dogs ofmedium-senior agewould deserve a renal
function evaluation together with a urinalysis at least every 12
months [15].
The canine population at high risk of proteinuric
nephropathy, for example, because of infectious diseases,
should be screened every 6 months.
Given the multiple conditions able to determine pro-
teinuria in dogs, epidemiological data represent a key factor
in setting up a screening of the population; based on high
prevalence of the disease, screening could be addressed not
only to breeds at risk for developing proteinuria or categories
potentially at risk such as dogs affected by vector-borne
diseases (e.g., leishmaniosis, ehrlichiosis, anaplasmosis, or
borreliosis), but also to the entire canine population. More-
over, epidemiological studies carried out in Belgium on a
healthy canine population revealed a high prevalence of renal
disease, thus leading the authors to propose the screening of
all senior dogs, even those considered healthy, to allow the
diagnosis of renal disease otherwise not identifiable at the
clinical visit [16]. In Italy, data regarding the prevalence of
proteinuria in dogs are not available.
Main aim of the present study was screening a canine
population, living in Italy and not known as being pro-
teinuric, by the urinary dipstick. When available, the UPC
values obtained from the urine of dogs positive at the
dipstick were evaluated to confirm or exclude protein-
uria and to determine its prevalence in the screened
population.
2. Material and Methods
The study was conducted in Italy over a period of 6 weeks.
Seven clinics participated and enrolled the dogs: 4 were
located in northern Italy (Milan, Turin, Parma, and Genoa)
and 3 in the south of Italy (Naples, Bari, and Palermo). All
dogs not known as being proteinuric, regardless of the age or
gender, were included. Females in oestrus and dogs known
or suspected to be affected by diseases of the genitourinary
tract and/or from any diseases determining proteinuria were
excluded. Dogs in treatment with drugs influencing the level
of proteinuria were also excluded from the study. All owners
were informed of the aims of the study and no dog underwent
invasive urine sampling (cystocentesis), if not required by
the practitioner for a diagnostic work-up not related to the
study.
2.1. Urine Collection and Storage of the Urine Samples.
All urine samples were collected by free catch or cysto-
centesis [8, 11]. The urine samples were then stored in a
dedicated container, kept at room temperature, and exam-
ined with the dipstick (Mindray) within one hour from
collection.
When possible, urinary sediment of samples positive to
the dipstick was evaluated and, if inactive, the UPC was
then determined. All urine samples undergoing the UPC
determination were immediately centrifuged at 1500 rpm for
10 minutes and the supernatant was then separated and put
into sterile tubes at −20∘C, if the UPC was not performed
within 6 hours from collection [17]. To measure the UPC
ratio, each clinic applied a standardized technique among the
ones already validated for the purpose.
2.2. Classification of the Results of the Urinary Test. Based on
the dipstick results, dogs were considered either [10]
(i) nonproteinuric (NP): dogs with negative result at
dipstick, or
(ii) suspected proteinuric (SP): dogs in which dipstick
gave any positive results (any colorimetric changes).
When the UPC determination was available, dogs classi-
fied as SP were further divided into three different substages
in accordance with the IRIS staging system [6]:
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Table 1: Dogs classified as non- or suspected proteinuric on the basis of the screening carried out with reactive strip for urine. In this table the
absolute numbers for geographical distribution and the relative percentages to facilitate the comparison of results for the different geographical
areas are reported.
Number of dogs Nonproteinuric dogs Suspected proteinuric dogs
Northern Italy 414 225/414 (54.3%) 189/414 (45.7%)
Southern Italy 742 430/742 (57.9%) 312/742 (42.1%)
Italy 1156 655/1156 (56.7%) 501/1156 (43.3%)
(i) Nonproteinuric (NP): dogs with UPC less than 0.2
(ii) Borderline proteinuric (BP): dogs with UPC between
0.2 and 0.5
(iii) Proteinuric (P): dogs with UPC above 0.5.
2.3. Statistical Analysis. The statistical analysis was per-
formed using MedCalc software (Frank Shoonjans, V.7.2.1.0)
and SPSS, version 13.0 for Windows. Differences in preva-
lence between different sites were assessed by the two-sided
chi-square test t. A P value <0.05 was considered statistically
significant.
3. Results
During the period of the study, a total of 1156 dogs were
screened for proteinuria, with no homogenous distribution
among the clinics: 414 dogs were screened in northern Italy
and 742 in southern Italy. Based on dipstick results 655
(56.6%) dogs were NP, while the remaining 501 (43.3%) were
SP. Among the NP dogs 225 out of 414 (54.3%) were in
northern Italy and 430 of 742 (57.9%) in southern Italy. One
hundred eighty-nine of 414 (45.7%) SP dogs were identified
in northern Italy and 312 of 742 (42.1%) in southern Italy. The
results of the screening with the urinary dipstick are reported
in Table 1, where the screened population was subdivided
based on the geographical distribution and the test results as
NP or SP.
A comparison was made between the two distributions
relating to the percentage of negativity and positivity to the
screening test performed by the dipstick and no statistical
difference was found between the North and South of Italy.
UPCwas available in 412 out of 501 SP samples at dipstick.
Based on the IRIS staging system (IRIS, 2015), 128/412 (31.0%)
were in substage BP, 135/412 (32.8%) were in substage P, and
149/412 (36.2%)were in substage NP. In total, UPC confirmed
proteinuria of any degree in 263 (63.86%) of 412 urine samples
analysed.
Although complete data were available only for 391 dogs
from 2 veterinary clinics located in northern Italy and one
in the south, there were no statistically significant differences
between dogs younger or older than 6 years of age (p>0.05).
4. Discussion
Based on dipstick results, the present study was suggestive of
low prevalence of nonproteinuric dogs and high prevalence
of suspected proteinuric ones from an apparently not-renal
affected population (not known to be nephropathic). These
results agreewith a previous article that revealed a high preva-
lence of proteinuria in dogs of advanced age and geriatrics
[16]. An interesting aspect of this study resided in the char-
acteristics of the canine population subjected to screening,
because all dogs were considered to be apparently clinically
healthy. The authors, confident that often the clinical signs
of renal disease are subtle and difficult to identify, concluded
by recommending measurement of proteinuria as part of
geriatric health screening [16]. The same recommendation
had already been provided by the American Animal Hospital
Association (AAHA) for dogs of mature age and seniors [18].
The AAHA suggestions lead us to lower the age in which
to begin the screening of the canine population for kidney
disease compared to what was suggested by Marynissen and
colleagues [8]. AAHA guidelines, in fact, consider these
dogs “mature,” which have reached 50% of the expected
lifespan. Similarly, the International Renal Interest Society
(IRIS) recommends the screening for renal disease once a
year for dogs of advanced age, even if they are apparently
healthy [6]. The IRIS also recommends a renal screening
every 6 months for all dogs at risk of renal disease including
in this category dogs affected by diseases known to determine
renal damage [6]. Despite the fact that most of the vector-
borne disease are to be encountered as causing renal damage,
a role of primary importance (at least for the prevalence in the
general canine population) could be attributed to conditions
potentially capable of determining a chronic stimulation of
the immune system, such as periodontal disease and certain
skin diseases [12, 13].
Suggestions provided by AAHA, IRIS, and other authors
must be taken in either the social realities or the geographical
locations where dogs live, as indications of screening from a
certain age and over may be not applicable in all contexts,
because of the presence of diseases potentially predisposing
the onset of renal damage [3, 4, 6, 14, 16, 18]. The suggestion
of screening the entire canine population to promote an early
diagnosis of proteinuric renal disease implies the assessment
of three elements: (i) the possibility to modify the prognosis
thanks to an early diagnosis and an effective treatment, (ii)
the possibility to perform the screening by a noninvasive
sampling and a low cost exam, and (iii) high prevalence of
the disease.
Proteinuric nephropathy is a disease usually at slow
progression (thus, a long-term one) and high incidence (par-
ticularly, in certain geographical areas endemic, for example,
for vector-borne diseases) and for the high prevalence of
other concomitant illnesses, such as, for example, chronic
cutaneous and periodontal disease. When epidemiologically
studied, both slow progression and high incidence are the
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two main characteristics of diseases at high prevalence. In
Spain, a prevalence of proteinuric renal disease ranging from
30.2% to 52.7% has been reported in the canine leishmaniosis
population [19]. The high prevalence of proteinuria reported
by the Spanish authors can obviously be related to leish-
maniosis, which is well known to cause glomerular damage
and consequently proteinuria. Italy, as a country with dif-
ferent geographical areas endemic for vector-borne diseases
(e.g., ehrlichiosis, anaplasmosis, and leishmaniosis), could
be epidemiologically comparable to Spain. Results of our
screening allowed us to classify only 56.6% of the population
of dogs as NP, which is a very low prevalence considering the
fact that the population tested was supposed to be healthy.
Furthermore, our data confirmed extremely high prevalence
of proteinuria with 43.3% of the tested dogs as SP at the
urinary dipstick, with 24.6% confirmed to be P or BP at the
UPC determination. However, this study has also revealed
no difference in the prevalence of nonproteinuric dogs in
northern Italy compared to the south of Italy. This is not in
line with what we had expected, the areas of southern Italy
being characterized by a higher prevalence of vector-borne
diseases (potentially determining renal damage) than the
areas of northern Italy [20].Many could be the reasons for the
data obtained, which show no statistical difference between
the prevalence of proteinuria in endemic and nonendemic
areas for vector-borne diseases. First of all, it should be
mentioned that many dog owners who live in the north of
Italy used to move to the coastal areas and the south of
Italy over summer, where endemic diseases transmitted by
vectors are widespread. Despite the use of vector repellents
and ectoparasiticides, there is the likelihood that dogs staying
for even short periods of time in endemic areas contract
infections that hesitate in seroconversion and subsequent
production of circulating immunocomplexes, with final renal
damage.The relevance of themovement of dogs via the rescue
associations, which have become particularly numerous in
recent years and frequently characterized by themovement of
dogs from southern Italy to the north, should also be stressed.
Coexisting diseases potentially causing renal damage could
represent a further element. Undoubtedly, the risk of peri-
odontal disease in dogs does not recognize geographical
differences (or, at least, we are not aware of this so far), and
other diseases may have contributed to determine a uniform
prevalence in the proteinuria distribution on Italian territory.
A final interesting data is the lack of statistically significant
difference based on age (p>0.05). Even if it is limited to only
three clinics of the seven enrolling the dogs to be screened,
there was in the canine population ages less than or equal
to/over 6 years.
This study has several limitations. First of all, the screen-
ing of the canine population has been carried out using the
urinary dipstick; a test with greater sensitivity and specificity
could have provided more accurate results; however it is
undoubted that a negative result at the dipstick is reliable
enough to identify dogs to be considered with high probabil-
ity of NP [9, 10]. Another important limitation is represented
by the multicentric structure of the trial, which led to the
use of different methods for the determination of the UPC,
as all clinics involved in the study used their own accredited
method. A recent study by Rossi G. and colleagues showed
how analytic variability and method-dependent differences
could affect substaging of patients according to the Interna-
tional Renal Interest Society (IRIS), particularly regarding
the values of UPC close to the cut-offs [21]. It is also worth
mentioning that the same author also demonstrated the same
method but different reagents can further influence a correct
substaging of the patient. [22]. These two potential biases
resulting from the determination of the UPC should in any
case be considered as belonging to the clinical practice. The
lack of statistically significant difference in the prevalence of
proteinuria among the structures participating in the study
could be consequent to the repetition of bias over the involved
structures. Finally, a further limitation is represented by
the selection of the population. For enrolment, the canine
population had to be considered as apparently not affected
by diseases capable of determining proteinuria. Thus, the
capacity of the veterinary surgeon had a fundamental role in
the selection of cases, as no laboratory examination could be
used to further classify the dogs. Although there may be some
bias, it is also true that these are the same encountered in daily
practice. Moreover, considering the prevalence of proteinuria
based on age, a limitation can be represented by the arbitrary
subdivision based on age, which does not consider size and/or
breed of dog. In fact, a dog belonging to a breed with an
average lifespan of 9 years has passed 50% of the expected
lifetime at 6 years, while a dog with an expected lifespan of
15 years has got only 40% of the expected lifetime at 6 years
[18]. Of course, the risk of kidney damage also increases in
relation to age and since no data about either breed or size
of the population studied is available, it was not possible to
evaluate a possible correlation between positivity/negativity
with the urinary dipstick and the biological age of the dogs.
It is possible that in some clinics dogs of advanced biological
age have prevailed on those of younger biological age.The fact
that among the three clinics in which complete data about
the age of the dogs subjected to screening were available
significant differences did not come out may suggest that
dogs of different breeds and/or sizes as well as different ages
(biological also) may have been well represented. Last but
not least we do not evaluate the serological positivity for
vector-borne disease of dogs, which underwent the screening
for proteinuria, and this makes it impossible to assume a
correlation between infectious disease and proteinuria itself
in the population studied and the possible enrollment of
subclinical patients.
5. Conclusions
The results of this study are suggestive of a low prevalence
of nonproteinuric dogs with a high prevalence of suspected
proteinuric dogs, together with the absence of statistically
significant differences based on geographical area, for pro-
teinuria of dogs living in Italy. These results also suggest
proposing periodical screening, possibly annually. All dogs
undergoing the screening were considered as not affected
by diseases capable of determining proteinuria by skilled
veterinary surgeons, based on the sole clinical examination;
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results of this study testify problems related to the correct
identification of the proteinuric disease solely on the basis of
the clinical visit and history of the dog.
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